APA

Keelapang P., Nitatpattana N., Suphatrakul A., Punyahathaikul S., Sriburi R., Pulmanausahakul R., Pichyangkul S., Malasit P., Yoksan S. & Sittisombut N. (20140428). Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. : Vaccine.

Chicago

Keelapang Poonsook, Nitatpattana Narong, Suphatrakul Amporn, Punyahathaikul Surat, Sriburi Rungtawan, Pulmanausahakul Rojjanaporn, Pichyangkul Sathit, Malasit Prida, Yoksan Sutee and Sittisombut Nopporn. 20140428. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. : Vaccine.

Harvard

Keelapang P., Nitatpattana N., Suphatrakul A., Punyahathaikul S., Sriburi R., Pulmanausahakul R., Pichyangkul S., Malasit P., Yoksan S. and Sittisombut N. (20140428). Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. : Vaccine.

MLA

Keelapang Poonsook, Nitatpattana Narong, Suphatrakul Amporn, Punyahathaikul Surat, Sriburi Rungtawan, Pulmanausahakul Rojjanaporn, Pichyangkul Sathit, Malasit Prida, Yoksan Sutee and Sittisombut Nopporn. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. : Vaccine. 20140428.